Lipocalin-type prostaglandin D synthase as a marker for the proliferative potential of melanocyte-lineage cells in the human skin

Journal of Dermatology

Volumn 39, Issue 8, 2012, Pages 699-704

  Shimanuki, Miwa ^a   Takeda, Kazuhisa ^b   Kawaguchi, Masakazu ^a   Suzuki, Tamio ^a   Shibahara, Shigeki ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

lipocalin type prostaglandin D syntheses; melanocyte; melanoma; nevus; retinoic acid

Indexed keywords

LIPOCALIN; PROSTAGLANDIN D SYNTHASE; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER TISSUE; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; MELANOCYTE; MELANOMA; NEVUS CELL; RNA INTERFERENCE; TISSUE SECTION;

AGED; AGED, 80 AND OVER; CELL PROLIFERATION; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; NEVUS; RNA, SMALL INTERFERING; SKIN; SKIN NEOPLASMS;

EID: 84864414042     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01485.x     Document Type: Article

References (21)

1. Takeda K, Takahashi NH, Shibahara S,. Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker. Tohoku J Exp Med 2007; 211: 201-221. (Pubitemid 46488377)
2. Hodgkinson CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993; 74: 395-404. (Pubitemid 23221714)
3. Goding CR,. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000; 14: 1712-1728. (Pubitemid 30602990)
4. Yasumoto K, Yokoyama K, Shibata K, Tomita Y, Shibahara S,. Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 1994; 14: 8058-8070. (Pubitemid 24373554)
5. mi-bw) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Hum Mol Genet 1999; 8: 1431-1441. (Pubitemid 29374076)
6. mi-bw mice, lacking melanocytes. J Biochem 2007; 141: 327-333. (Pubitemid 46770385)
7. Takeda K, Yokoyama S, Aburatani H, et al. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF. Biochem Biophys Res Commun 2006; 339: 1098-1106. (Pubitemid 41790577)
8. Urade Y, Hayaishi O,. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 2000; 1482: 259-271.
9. Tanaka T, Urade Y, Kimura H, Eguchi N, Nishikawa A, Hayaishi O,. Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter. J Biol Chem 1997; 272: 15789-15795. (Pubitemid 27265556)
10. Fitzpatrick FA, Stringfellow DA,. Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential. Proc Natl Acad Sci USA 1979; 76: 1765-1769. (Pubitemid 9175392)
11. Bhuyan BK, Adams EG, Badiner GJ, Li LH, Barden K,. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. Cancer Res 1986; 46: 1688-1693. (Pubitemid 16121492)
12. Takeda K, Takahashi N-H, Yoshizawa M, Shibahara S,. Lipocalin-type prostaglandin D synthase as a regulator of the retinoic acid signaling in melanocytes. J Biochem 2010; 148: 139-148.
13. Meyskens FL Jr, Fuller BB,. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res 1980; 40: 2194-2196. (Pubitemid 10082224)
14. Romero C, Aberdam E, Larnier C, Ortonne JP,. Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J Cell Sci 1994; 107 (Pt 4): 1095-1103.
15. Paek CS, Sober JA, Tsao H, Mihm CM Jr, Johnson MT,. Cutaneous Melanoma. In:, Wolff K., et al. eds. Fitzpatrick's Dermatology in General Medicine, 7th edn. NY: McGraw-Hill, 2008; 1134-1159.
16. Grichnik MJ, Rhodes RA, Sober JA,. Benign neoplasias and hyperplasias of melanocytes. In:, Wolff K., et al. eds. Fitzpatrick's Dermatology in General Medicine, 7th edn. NY: McGraw-Hill, 2008; 1099-1116.
17. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM,. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996; 62: 155-169. (Pubitemid 26140102)
18. Davis AA, Bernstein PS, Bok D, Turner J, Nachtigal M, Hunt RC,. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci 1995; 36: 955-964.
19. Schreiber E, Matthias P, Müller MM, Schaffner W,. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419. (Pubitemid 19198635)
20. Takeda K, Yokoyama S, Yasumoto K, et al. OTX2 regulates expression of DOPAchrome tautomerase in human retinal pigment epithelium. Biochem Biophys Res Commun 2003; 300: 908-914. (Pubitemid 36259848)
21. Satarug S, Wisedpanichkij R, Takeda K, et al. Prostaglandin D2 induces heme oxygenase-1 mRNA expression through the DP2 receptor. Biochem Biophys Res Commun 2008; 377: 878-883.